Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ KCNK1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5101757
Description
Antibody detects endogenous levels of total KCNK1.
This gene encodes one of the members of the superfamily of potassium channel proteins containing two pore-forming P domains. The product of this gene has not been shown to be a functional channel, however, it may require other non-pore-forming proteins for activity. [provided by RefSeq, Jul 2008].
Specifications
KCNK1 | |
Polyclonal | |
Unconjugated | |
Kcnk1 | |
AI788889; double-pore potassium channel; DPK; HOHO; HOHO1; Inward rectifying potassium channel protein TWIK-1; K2P1; K2p1.1; Kcnk1; kcnk1 {ECO:0000312; KCNO1; Potassium channel K2P1; potassium channel KCNO1; Potassium channel subfamily K member 1; potassium channel TWIK-1; potassium channel, subfamily K, member 1; potassium channel, two pore domain subfamily K, member 1; potassium inwardly-rectifying channel, subfamily K, member 1; potassium two pore domain channel subfamily K member 1; putative potassium channel TWIK; rabKCNK1; RGD:621447}; rTWIK; tandem of P domains in a weak inward rectifying K+ channel 1; Twik; TWIK1; TWIK-1; two-pore potassium channel; Unknown (protein for MGC:142788) | |
Rabbit | |
Affinity chromatography | |
RUO | |
16525, 3775, 59324 | |
-20°C | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
1 mg/mL | |
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
O00180, O08581, Q9Z2T2 | |
Kcnk1 | |
A synthesized peptide derived from human KCNK1(Accession O00180), corresponding to amino acid residues L34-E84. | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction